Cancer Drug Company Accused of Hiding Cheap Alternative!
[youtube=https://www.youtube.com/watch?v=BTGye7kA6rM]
- Cancer Drug Company Accused of Hiding Cheap Alternative!
by CHRISTINA SARICH, http://naturalsociety.com/
Artificially jacking up prices.
Pharmaceutical companies have been known to discredit natural, cheap solutions that compete with their high-dollar drugs. Now, the British Medical Journal has unraveled new research revealing how the makers of a cancer drug are blocking public access to a cheaper, safe, and effective alternative.
–
The BMJ explains that Novartis, a company which markets a licensed cancer drug known as Lucentis, which is used for macular degeneration, tried to derail research on another treatment called Avastin. Novartis denies this claim, but they have the market cornered because they sell the only officially licensed drug in the UK.
–
Many doctors use Avastin as a cheaper but unlicensed alternative to treat wet age-related macular degeneration (AMD), which affects more than 26,000 people in the UK annually. Approximately 11 million in the US have been diagnosed with some sort of macular degeneration with that number expected to double by 2050.
–
Lucentis costs the NHS around £740 per dose (around $1,100 US dollars). Avastin, on the other hand, would cost between £50 and £65 per dose.
–
Doctors still prescribe it, though it hasn’t been authorized to be used for macular degeneration. Some doctors are concerned about being personally liable if they prescribe the cheaper drug, and therefore, don’t.
–
read more!
end
Reblogged this on HumansinShadow.wordpress.com.
Reblogged this on TheFlippinTruth.